Intra-Cellular Therapies SG&A Expenses 2013-2024 | ITCI

Intra-Cellular Therapies sg&a expenses for the twelve months ending December 31, 2024 were $0.504B, a 23.09% increase year-over-year.

  • Intra-Cellular Therapies annual sg&a expenses for 2024 were $0.504B, a 23.09% increase from 2023.
  • Intra-Cellular Therapies annual sg&a expenses for 2023 were $0.41B, a 14.24% increase from 2022.
  • Intra-Cellular Therapies annual sg&a expenses for 2022 were $0.359B, a 31.61% increase from 2021.

Intra-Cellular Therapies SG&A Expenses 2013-2024 | ITCI

  • Intra-Cellular Therapies annual sg&a expenses for 2024 were $0.504B, a 23.09% increase from 2023.
  • Intra-Cellular Therapies annual sg&a expenses for 2023 were $0.41B, a 14.24% increase from 2022.
  • Intra-Cellular Therapies annual sg&a expenses for 2022 were $0.359B, a 31.61% increase from 2021.